These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 29454981)
1. Natural products as inhibitors of prostaglandin E Koeberle A; Werz O Biotechnol Adv; 2018 Nov; 36(6):1709-1723. PubMed ID: 29454981 [TBL] [Abstract][Full Text] [Related]
2. Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E Cheung SY; Werner M; Esposito L; Troisi F; Cantone V; Liening S; König S; Gerstmeier J; Koeberle A; Bilancia R; Rizza R; Rossi A; Roviezzo F; Temml V; Schuster D; Stuppner H; Schubert-Zsilavecz M; Werz O; Hanke T; Pace S Eur J Med Chem; 2018 Aug; 156():815-830. PubMed ID: 30053720 [TBL] [Abstract][Full Text] [Related]
3. Rotational constriction of curcuminoids impacts 5-lipoxygenase and mPGES-1 inhibition and evokes a lipid mediator class switch in macrophages. Rao Z; Caprioglio D; Gollowitzer A; Kretzer C; Imperio D; Collado JA; Waltl L; Lackner S; Appendino G; Muñoz E; Temml V; Werz O; Minassi A; Koeberle A Biochem Pharmacol; 2022 Sep; 203():115202. PubMed ID: 35932797 [TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin. Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Dual 5-Lipoxygenase/Microsomal Prostaglandin E2 Synthase-1 Inhibitory Effect of Natural and Synthetic Acronychia-Type Isoprenylated Acetophenones. Svouraki A; Garscha U; Kouloura E; Pace S; Pergola C; Krauth V; Rossi A; Sautebin L; Halabalaki M; Werz O; Gaboriaud-Kolar N; Skaltsounis AL J Nat Prod; 2017 Mar; 80(3):699-706. PubMed ID: 28240894 [TBL] [Abstract][Full Text] [Related]
6. Ligand-based Modeling for the Prediction of Pharmacophore Features for Multi-targeted Inhibition of the Arachidonic Acid Cascade. Saroj Devi N; Shanmugam R; Ghorai J; Ramanan M; Anbarasan P; Doble M Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991413 [TBL] [Abstract][Full Text] [Related]
7. Structure-based screening for the discovery of 1,2,4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid biosynthesis pathways. Potenza M; Sciarretta M; Chini MG; Saviano A; Maione F; D'Auria MV; De Marino S; Giordano A; Hofstetter RK; Festa C; Werz O; Bifulco G Eur J Med Chem; 2021 Nov; 224():113693. PubMed ID: 34315041 [TBL] [Abstract][Full Text] [Related]
8. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
9. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review. Koeberle A; Werz O Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418 [TBL] [Abstract][Full Text] [Related]
10. Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E Gür Maz T; Dahlke P; Gizem Ergül A; Olğaç A; Jordan PM; Çalışkan B; Werz O; Banoglu E Bioorg Chem; 2024 Jun; 147():107383. PubMed ID: 38653151 [TBL] [Abstract][Full Text] [Related]
11. Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation. Bruno F; Errico S; Pace S; Nawrozkij MB; Mkrtchyan AS; Guida F; Maisto R; Olgaç A; D'Amico M; Maione S; De Rosa M; Banoglu E; Werz O; Fiorentino A; Filosa R Eur J Med Chem; 2018 Jul; 155():946-960. PubMed ID: 30015253 [TBL] [Abstract][Full Text] [Related]
12. Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1. Greiner C; Zettl H; Koeberle A; Pergola C; Northoff H; Schubert-Zsilavecz M; Werz O Bioorg Med Chem; 2011 Jun; 19(11):3394-401. PubMed ID: 21570310 [TBL] [Abstract][Full Text] [Related]
13. Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade. Sala A; Proschak E; Steinhilber D; Rovati GE Biochem Pharmacol; 2018 Dec; 158():161-173. PubMed ID: 30315753 [TBL] [Abstract][Full Text] [Related]
14. Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy. Gürses T; Olğaç A; Garscha U; Gür Maz T; Bal NB; Uludağ O; Çalışkan B; Schubert US; Werz O; Banoglu E Bioorg Chem; 2021 Jul; 112():104861. PubMed ID: 33826984 [TBL] [Abstract][Full Text] [Related]
15. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo. Hanke T; Dehm F; Liening S; Popella SD; Maczewsky J; Pillong M; Kunze J; Weinigel C; Barz D; Kaiser A; Wurglics M; Lämmerhofer M; Schneider G; Sautebin L; Schubert-Zsilavecz M; Werz O J Med Chem; 2013 Nov; 56(22):9031-44. PubMed ID: 24171493 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of COX-2/mPGES-1 and 5-LOX in macrophages by leonurine ameliorates monosodium urate crystal-induced inflammation. Liu Y; Duan C; Chen H; Wang C; Liu X; Qiu M; Tang H; Zhang F; Zhou X; Yang J Toxicol Appl Pharmacol; 2018 Jul; 351():1-11. PubMed ID: 29763636 [TBL] [Abstract][Full Text] [Related]
17. A review on mPGES-1 inhibitors: From preclinical studies to clinical applications. Bergqvist F; Morgenstern R; Jakobsson PJ Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106383. PubMed ID: 31698145 [TBL] [Abstract][Full Text] [Related]
18. Munronia pinnata (Wall.) Theob.: unveiling phytochemistry and dual inhibition of 5-lipoxygenase and microsomal prostaglandin E2 synthase (mPGES)-1. Napagoda M; Gerstmeier J; Koeberle A; Wesely S; Popella S; Lorenz S; Scheubert K; Böcker S; Svatoš A; Werz O J Ethnopharmacol; 2014 Feb; 151(2):882-90. PubMed ID: 24315851 [TBL] [Abstract][Full Text] [Related]
19. A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors. Lauro G; Terracciano S; Cantone V; Ruggiero D; Fischer K; Pace S; Werz O; Bruno I; Bifulco G ChemMedChem; 2020 Mar; 15(6):481-489. PubMed ID: 32022480 [TBL] [Abstract][Full Text] [Related]
20. Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP). Ho JD; Lee MR; Rauch CT; Aznavour K; Park JS; Luz JG; Antonysamy S; Condon B; Maletic M; Zhang A; Hickey MJ; Hughes NE; Chandrasekhar S; Sloan AV; Gooding K; Harvey A; Yu XP; Kahl SD; Norman BH Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129800. PubMed ID: 33246032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]